fda_approval · nda · info
NOVARTIS — NDA approval: KISQALI (unspecified)
- Event date
- 2026-07-01 00:00:00Z
- Observed
- 2026-07-09 22:53:30Z
- Source ID
- NDA209092-27
- Payload hash
- 685059c195dcdf57bbe760ff…
Summary
NOVARTIS received a priority supplemental NDA approval for KISQALI (unspecified) on 2026-07-01. Dosage form: TABLET. Application #: NDA209092.
Entities
Informational only. Not legal, financial, or medical advice.